Menu ×


Drug Testing Equipment Market Segmentation by Product (Consumables, Urine Testing Kits, Rapid Test Devices, Breathalyzer, Chromatography, and Others); by Sample (Blood, Urine, Oral Fluids, Breath, and Others); by Application (Radiology, Ultrasound, In Vitro Diagnostic, and Others); and by End-User (Laboratories, Research Institutes, Hospitals, and Others) – Global Demand Analysis & Opportunity Outlook 2031

  • Text Size:

Extensive insights into the Growth of Drug Testing Equipment Market amidst COVID-19

Get the detailed impact analysis of COVID-19 that has disrupted the entire world and affected many industries.

Request Insights


  • February, 2021: Sandoz announced the acquisition of cephalosporin antibiotics business of GSK, to expand its portfolio in manufacturing drugs and medicines.

  • March, 2018: Butterfly Network, Inc. launched an augmented-reality capability to remotely guide Butterfly iQ ultrasound scanners.

Global Drug Testing Equipment Market Highlights over 2022 – 2031

The global drug testing equipment market is estimated to grow at a CAGR of ~15% over the forecast period, i.e., 2022 – 2031. The growth of the market can be attributed to the increasing demand for novel drugs and treatment methods for diseases, along with higher adoption of technology in the healthcare industry. Moreover, government has stringent regulations for testing any drug before its approval for sale, which is further projected to play a crucial role in the growth of the drug testing equipment market.

Drug Testing Equipment Market

Get more information on this reportDownload Sample PDF

Furthermore, the growing research activities for the development of new drugs are anticipated to fuel the market growth. According to the data by the World Bank, research and development expenditure amounted to 2.204% of the GDP in 2018.

Research & Development Expenditure

Moreover, growing patient pool of various genetic, and non-genetic disorders, rising prevalence of lifestyle diseases, such as, diabetes, hypertension, cardiovascular diseases, and others, and surge in transmission of communicable diseases, are further estimated to collectively drive the market growth. For instance, requirement for vaccine for fast spreading diseases, such as, COVID-19, played a significant role in the growth of the market. Furthermore, the increasing health awareness amongst people has also led to surge in demand for effective drugs and medicines, which is projected to promote the market growth. Furthermore, the growing technological advancement in the healthcare sector, backed by rising healthcare expenditure, is forecasted to boost the market growth. According to the data by the World Bank, 9.858% of the global gross domestic product (GDP) was spent on healthcare in 2018.

The market is segmented by product into consumables, urine testing kits, rapid test devices, Breathalyzer, chromatography, and others. Out of these, the rapid test devices segment is anticipated to gain notable growth in the global drug testing equipment market over the forecast period on account of increasing demand for drugs backed by higher health awareness amongst the people, post COVID-19 pandemic. Rapid test devices deliver quick results, which allows researchers to carry on multiple tests in a shorter span of time, which, in turn, increases the accuracy of tests and decreases the time taken. Such factors are anticipated to boost the segment growth. 

Major Macro-Economic Indicators Impacting the Market Growth

Healthcare Expenditure per Capita

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Drug Testing Equipment Market Regional Synopsis

On the basis of geographical analysis, the global drug testing equipment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Asia Pacific region is estimated to witness noteworthy growth over the forecast period on the back of increasing government and private investment in the healthcare sector, coupled with the advancement in technology. Moreover, growing investment in research activities in countries, such as, China, and Japan, is expected to boost the market growth. The market in the North America region is anticipated to gain the largest market share throughout the forecast period on account of presence of major pharmaceutical companies in the region, along with high investment for research and development of new drugs.

Healthcare Expenditure per Capita

Get more information on this reportDownload Sample PDF

The global drug testing equipment market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global drug testing equipment market includes the following segments:

By Product

  • Consumables
  • Urine Testing Kits
  • Rapid Test Devices
  • Breathalyzer
  • Chromatography
  • Others

By Sample

  • Blood
  • Urine
  • Oral Fluids
  • Breath
  • Others

By Application

  • Radiology
  • Ultrasound
  • In Vitro Diagnostic
  • Others

By End-User

  • Laboratories
  • Research Institutes
  • Hospitals
  • Others

Growth Drivers

  • Increasing Demand for New Drugs and Treatment Methods
  • Strict Regulations for Proper Drug Testing
  • Growing Global R&D Expenditure


  • High Cases of Drug Abuse, Specially, Narcotics
  • Ban on Certain Drug Testing in Some Countries

Top Featured Companies Dominating the Market

  • Quest Diagnostics Incorporated
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis 
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific, Inc.
  • Siemens AG
  • Bio-Rad Laboratories, Inc.
  • Butterfly Network, Inc.
  • Cordant Health Solutions
  • Legacy Medical Services, LLC
  • Omega Laboratories, Inc.
  • GE Healthcare


Related Reports

Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved